| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.0004 |